Tenofovir Disoproxil Fumarate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tenofovir Disoproxil Fumarate
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Tenofovir Disoproxil Fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

64 API Suppliers, 30 USDMF, 2 JDMF, 20 EU WC, 22 KDMF, 24 NDC API, 35 Listed Suppliers, $ API Reference Price

64 API Suppliers
30 USDMF
2 JDMF
20 EU WC
22 KDMF
24 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

254 FDF Dossiers, 82 FDA Orange Book, 23 Europe, 32 Canada, 14 Australia, 86 South Africa, 17 Listed Dossiers

254 FDF Dossiers
82 FDA Orange Book
23 Europe
32 Canada
14 Australia
86 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 100MG;300MG;300MG, TABLET;ORAL - 300MG;300MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG, TABLET;ORAL - 300MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 100MG;300MG;300MG
TABLET;ORAL - 300MG;300MG
TABLET;ORAL - 150MG
TABLET;ORAL - 200MG
TABLET;ORAL - 250MG
TABLET;ORAL - 300MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 33 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 44 Direct Compression, 34 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 30 Granulation, 28 Solubilizers, 25 Thickeners and Stabilizers, 21 Co-Processed Excipients, 19 Taste Masking, 19 Parenteral, 17 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Topical, 15 Film Formers & Plasticizers, 8 API Stability Enhancers, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

86 Fillers, Diluents & Binders
54 Coating Systems & Additives
44 Direct Compression
34 Controlled & Modified Release
32 Disintegrants & Superdisintegrants
30 Granulation
28 Solubilizers
25 Thickeners and Stabilizers
21 Co-Processed Excipients
19 Taste Masking
19 Parenteral
17 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Topical
15 Film Formers & Plasticizers
8 API Stability Enhancers
8 Emulsifying Agents
6 Surfactant & Foaming Agents
5 Empty Capsules
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 122 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
122 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 17 Finished Drug Prices, 32 Annual Reports

2 US Medicaid Prescriptions
17 Finished Drug Prices
32 Annual Reports

MARKET PLACE

7 APIs, 6 FDF Dossiers

7 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 1 US Exclusivities, 2 Health Canada Patents

36 US Patents
1 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 4 Others

4 USP
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 154 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gilead Sciences Canada Inc.

filter Patent Reset all filters

2 All

01 12261619

02 12298059

filter Product Reset all filters

2 All

01 2Tenofovir Disoproxil Fumarate

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 12017-07-25

02 12018-07-23

Product Main Page

01

Gilead Sciences Canada Inc.

Tenofovir Disoproxil Fumarate

Pharma, Lab & Chemical Expo

Not Confirmed

Gilead Sciences Canada Inc.

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-23

Date Granted : 2008-12-30

Tenofovir Disoproxil Fumarate

Brand Name : VIREAD

Patent Number : 2298059

Filing Date : 1998-07-23

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-23

Date Granted : 2008-12-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gilead Sciences Canada Inc.

Tenofovir Disoproxil Fumarate

Pharma, Lab & Chemical Expo

Not Confirmed

Gilead Sciences Canada Inc.

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-07-25

Date Granted : 2006-05-23

Tenofovir Disoproxil Fumarate

Brand Name : VIREAD

Patent Number : 2261619

Filing Date : 1997-07-25

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-07-25

Date Granted : 2006-05-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?